Podcasts about Opioid overdose

Steven May is a federal whistleblower who took on one of the biggest pharmaceutical companies in the world: Purdue Pharma. His case, which once reached the Supreme Court, exposed what he believes was a calculated fraud that led to the approval of OxyContin and helped create the opioid crisis. In this powerful interview, May shares the eye-opening details he uncovered during discovery. He reveals how his legal battle, though ultimately dismissed on a technicality, would have argued that if Purdue had not made false claims about the drug's efficacy, it never would have been approved. This is a story of a David-versus-Goliath struggle, where one man's pursuit of justice uncovered a systemic failure with devastating consequences. May's experience resonates with other high-profile whistleblower cases, such as that of **Brooke Jackson** against Pfizer's mRNA vaccines. He's previously been interviewed by major news outlets like *The New Yorker* and France 24, and now, he's ready to tell his complete story. Tune in to hear how Steven May's fight against corporate power sheds light on the origins of the opioid crisis and the critical role whistleblowers play in holding powerful institutions accountable. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Show notes at pharmacyjoe.com/episode1048. In this episode, I'll discuss how often opioid overdose patients also have a benzodiazepine co-exposure. The post 1048: How often do opioid overdose patients also have benzodiazepine co-exposure? appeared first on Pharmacy Joe.

Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients  JAMA Network Open This cohort study of 1,683 patients assessed if there are racial and ethnic disparities in treatment referral rates among patients in the emergency department (ED) with opioid overdose.  It found a statistically significant difference in the proportion of Black patients who received an outpatient treatment referral (5.7%) compared with White patients (9.6%). These findings suggest that Black patients presenting to the ED with opioid overdose may be less likely to receive outpatient treatment referrals, underscoring the need for targeted intervention and enhanced referral processes.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Hundreds of thousands of lives have been lost to the ever-evolving opioid overdose epidemic. We will discuss where Cleveland and Cuyahoga County stand with regards handling the crisis. Wednesday on the "Sound of Ideas," we'll start by talking about where Northeast Ohio stands in the approach and treatment of those impacted by opioids. We'll also discuss why we're seeing different shifts in drug overdose deaths, and what we can do to prevent a future spike.  Later, we talk to Case Western Reserve University world affairs professor, Kathyrn Lavelle, Ph.D. She has written a book that traces U.S involvement in the Arctic from the founding of the nation up through present day.

Dr. Joseph Kanter, ASTHO CEO, Dr. Scott Harris, ASTHO President, Dr. Susan Kansagra, ASTHO Chief Medical Officer, Dr. Lindsay Weaver of Indiana, Dr. James McDonald of New York, and Dr. Ralph Alvarado of Tennessee, share more from Tuesday's deskside briefing on the impact of Nutrition on Chronic Disease; Kelly Dougherty, Deputy Commissioner at the Vermont Department of Health, explains how the state's public health strategies reduced opioid overdose deaths; and an ASTHO Blog Article shows that states across the country are reassessing vaccine policy and public health powers due to legislative changes that impact public health authority and access to vaccines. Vermont Department of Health: Deaths from Opioid Overdose Declined Significantly in 2024 ASTHO Blog Article: States Reassessing Vaccine Policy and Public Health Powers ASTHO Web Page: STAR Center  

Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study Drug and Alcohol Dependence People who experience a nonfatal opioid overdose are at increased risk of subsequent overdose but is also a potential moment to intervene. In this cohort study, they used statewide data from Connecticut to assess differences in overdose outcomes in the year following a nonfatal overdose by treatment type received. Overall, 56% of patients received no treatment, while 35% received medication for opioid use disorder (MOUD) (25% buprenorphine and 11% methadone) and 21% received inpatient treatment (detox and/or extended inpatient). Both methadone (aHR=0.41) and buprenorphine (aHR=072) were associated with decrease in subsequent overdose, whereas neither detox nor prolonged inpatient treatment were associated with decreased overdose. These findings further support the importance of MOUD and the need to increase access to treatment in this high-risk population.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Drug overdose deaths in the U.S. plunged last year to their lowest level since 2019, according to the CDC. In 2024, nationwide overdose deaths fell by nearly 30,000 from the year before, a drop of about 27 percent. There were declines across all categories of drug use, including opioids, the source of most overdose deaths over the past decade. John Yang discussed more with Brian Mann of NPR. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Drug overdose deaths in the U.S. plunged last year to their lowest level since 2019, according to the CDC. In 2024, nationwide overdose deaths fell by nearly 30,000 from the year before, a drop of about 27 percent. There were declines across all categories of drug use, including opioids, the source of most overdose deaths over the past decade. John Yang discussed more with Brian Mann of NPR. PBS News is supported by - https://www.pbs.org/newshour/about/funders

The Indiana Pacers are moving on to the second round of playoffs. A new tactical urbanism project is set up along a busy cross-section of Indianapolis neighborhoods. A massive art installation has a new permanent home at the International School of Indiana. A group of researchers are hoping to incorporate virtual reality gaming technology to teach people how to reverse an opioid overdose. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

Opioid toxicity is a major and growing challenge across the UK and beyond, with nearly 10 deaths every day from opioid overdose and over a million adults using Class A drugs annually, the impact on emergency services is enormous. In this episode, we're diving deep into the recognition and management of acute opioid toxicity in the emergency setting, including the reversal using naloxone. We'll run through; The scale of the problem, including the rise of novel synthetic opioids like fentanyl and nitazenes. A breakdown of opioid pharmacology, including receptor types, potencies, and onset of action. How to identify classic and mixed presentations of opioid overdose. Best practice on naloxone dosing, routes of administration, and when to start infusions. The risk of acute withdrawal and how to manage it with care. How to approach mixed overdoses, cardiac arrests involving opioids, and nebulised naloxone. And finally, the importance of holistic care, safeguarding, and onward referral to support recovery. Whether you're in ED, prehospital care, or just want to sharpen your tox knowledge, this episode's packed with take-home learning. Oh, and yes... Gangs of London gets a shout-out too. Once again we'd love to hear any thoughts or feedback either on the website or via X @TheResusRoom! Simon, Rob & James

Dr. Sameer Vohra, Director of the Illinois Department of Public Health and an ASTHO Member, tells us how Illinois worked to successfully reduce opioid overdoses; and Beth Giambrone, ASTHO Senior Analyst of State Health Policy, recaps some of the efforts across the country to combat tobacco use. ASTHO Blog Article: Tobacco Policy Roundup – Smoking Rates Down but Youth E-Cigarette Use Rising ASTHO Web Page: Stay Informed  

In this episode of the Prehospital Care Research Forum's Journal Club, we discuss the findings of a qualitative study examining the acceptability of providing take-home naloxone kits by EMS to individuals at risk of opioid overdose. Discover the insights from the study, including patient perspectives, potential barriers, and the implications for overdose prevention strategies. Join us for a thought-provoking conversation on how EMS can play a pivotal role in combating the opioid crisis.https://www.tandfonline.com/doi/full/10.1080/10903127.2024.2435034?src=

Opioid overdoses don't have to be fatal if the person gets help in time.In recent years naloxone, a medication that reverses opioid overdoses, has become more widely available in the United States. Narcan, a nasal spray version of naloxone, became available without prescription in pharmacies in 2023. That means more people can help reverse overdoses. Despite showing signs of decline, the number of people dying nationwide from overdoses eclipsed 100,000 annually from 2020 to 2023, according to national health data.Host Elahe Izadi talks with producer Elana Gordon about the lifesaving effects of the medication. They walk through the steps of how to use Narcan and what it feels like to experience an opioid overdose reversal. Today's show was produced by Ariel Plotnick. It was edited by Lucy Perkins with help from Alison MacAdam and mixed by Sam Bair. Download The Post's step-by-step guide for how to administer the naloxone nasal spray here.Subscribe to The Washington Post here.

Mia Christopher, Research Epidemiologist at RTI International, explains how the Opioid Overdose Community Decision Tool could benefit public health; Lexa Giragosian, ASTHO Senior Analyst for Maternal and Child Health, tells us why she believes her blog article on adolescent mental health resonated with so many; and an ASTHO toolkit is aimed at improving working relationships between a health agency's internal staff and external partners. NIH Heal Initiative Web Page: Overdose Crisis Community Decision Tool ASTHO Blog Article: Reducing the Impact of Eating Disorders on Adolescent Girls ASTHO Web Page: Engaging Partners in a Virtual Space ASTHO Web Page: 2025 Legislative Prospectus Series  

Today is Friday, Jan. 10. Here are some of the latest headlines from the Fargo, North Dakota area. InForum Minute is produced by Forum Communications and brought to you by reporters from The Forum of Fargo-Moorhead and WDAY TV. For more news from throughout the day, visit InForum.com.

Mendocino County ranked #1 for opioid overdoses among California counties in 2021. Today, Mendocino County ranks 10th. We explore the reasons why in this newscast. In addition to organizations like Fort Bragg's Care Response Unit, Mendonoma Health Alliance in Gualala, MCAVHN Care and Prevention Network in Ukiah, and SafeRX Mendocino in Willits, there are individuals like Marji Brunelle who have made it their mission to prevent overdoses, particularly among the formerly incarcerated people who may also be houseless.

Dr. Robert Gereau a professor of anesthesiology at Wash U School of Medicine and director of Wash U's Pain Center joins KMOX Health Editor Fred Bodimer.

The US wants Americans in Lebanon out as Israel's aerial and ground offensive against the Hezbollah militant group there continues. Vice President Kamala Harris's campaign has new proposals targeting Black male voters. Fewer than 5% of homeowners in many Central Florida counties have flood insurance. A new study by the CDC reports that overdose deaths involving opioids fell by 3% in 2023. Plus, this year's Nobel Prize in economics goes to three men who studied why some countries are richer than others. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In episode 1745, Jack and Miles are joined by comedian, writer, and co-host of Yo, Is This Racist?, Andrew Ti, to discuss… Easier To Make Up Racist Lies Than Offer Solutions, Overdose Deaths In The U.S. Are Plummeting, The Meaning of the Word AI Is Changing and more! Easier To Make Up Racist Lies Than Offer Solutions Why Trump's lies about Haitians are different Overdose Deaths In The U.S. Are Plummeting Provisional Drug Overdose Death Counts NPR Exclusive: U.S. overdose deaths plummet, saving thousands of lives Are overdoses down and why? I Learned How to Treat an Opioid Overdose in 90 Minutes US Overdose Deaths Declined for the First Time in Decades The Meaning of the Word AI Is Changing LISTEN: Dream State by Kamasi WashingtonSee omnystudio.com/listener for privacy information.

Many (if not most) people are worried about world and local events. Today's tip is focused on finding empowering & effective actions that become a sense of self-care. Find what actually helps and doing it is a powerful way to reduce this kind of anxiety. Mark your calendars for Thursday 8/29, for the 3rd annual live stream for Opioid Overdose awareness. Listen, watch, or join the program live! See links and times at: www.dwighthurst.com/live 

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:   The good — Genentech's oral weight loss drug shows promise  The bad — FDA denies accelerated approval for Agenus' cancer drug  The ugly — Orexo's opioid overdose drug rejected again 

Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences.    The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-cell engager (BiTE®) therapy targets CD19 surface antigens on B cells, allowing T cells to recognize and eliminate malignant B cells. The approval was based on the Phase 3 E1910 trial showing improved overall survival with blinatumomab plus chemotherapy compared to chemotherapy alone.   The FDA has approved roflumilast cream 0.15% (Zorvye) for treating mild to moderate atopic dermatitis (AD) in patients aged 6 years and older. This steroid-free, once-daily topical treatment is a selective, highly potent phosphodiesterase 4 (PDE4) inhibitor designed for long-term disease control. The approval was based on phase 3 studies showing significant improvements in disease clearance, itch reduction, and overall skin condition compared to the vehicle group.   The FDA has approved a new 6mg single-dose prefilled syringe for faricimab-svoa (Vabysmo), facilitating easier administration for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Faricimab-svoa is a VEGF and Ang-2 inhibitor, now available in a ready-to-use format. This approval provides an alternative to the existing single-dose vial and is granted to Genentech.   The FDA is set to decide on OX124, a high-dose naloxone nasal rescue medication designed to reverse opioid overdoses, with the PDUFA date set for July 15, 2024. Developed by Orexo, OX124 offers rapid absorption, high bioavailability, and enhanced stability, addressing the critical need for potent rescue medications due to the high rate of synthetic opioid overdoses. If approved, OX124's launch is anticipated later in 2024.   The FDA accepted an NDA for vonoprazan (Voquezna) tablets for treating heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD) in adults, with the PDUFA date set for July 19, 2024. Vonoprazan is a potassium-competitive acid blocker (PCAB) offering an alternative to traditional proton pump inhibitors (PPIs). Non-Erosive GERD, affecting 38 million U.S. adults, is characterized by reflux-related symptoms without esophageal mucosal erosions, impacting quality of life with symptoms like heartburn and chest pain.  

Opioid overdoses—mainly fentanyl—killed more than 4,000 Minnesotans from 2019 through 2023. And there have been dramatic racial disparities that have only grown as death rates show signs of maybe leveling off. This is especially true for Native Americans, who in those five years were 15 times more likely to suffer a fatal overdose than white people. Minnesotans who did not go to college were also more likely to die from opioids. Antony Stately is a clinical psychologist and the President and Executive Officer of the Native American Community Clinic. Dr. Dziwe Ntaba is an emergency medicine physician and an assistant professor at the University of Minnesota Medical School.These two health care providers are working to prevent more deaths from opioid overdose. They joined MPR News Host Cathy Wurzer to talk about what's behind the numbers—and what they leave out.

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths The New England Journal of Medicine  HEALing (Helping to End Addiction Long-term Initiative) Communities Study (HCS) investigators examined the potential of the community-engaged, data-driven Communities That HEAL (CTH) intervention to reduce the rate of opioid-related overdose deaths in highly affected communities. Intervention communities implemented hundreds of strategies to expand opioid overdose education and naloxone distribution, the use of medications for opioid use disorder, and safety measures for prescription opioid use, as well as communication campaigns to support these efforts. Although there were no significant between-group differences in the rate of opioid-related overdose deaths, the trial showed that the CTH community-engaged intervention, with its leveraging of community coalitions and a data-driven approach, can bring about meaningful progress in implementing evidence-based practices.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Radio Boston learns more about the newest overdose death data from the state with WBUR's Martha Bebinger.

In this week's health segment, Fred Bodimer reports on significant developments and warnings in the medical world. The FDA has approved Amgen's innovative new drug, tarlatamab, which significantly extends the life expectancy for patients with aggressive small cell lung cancer. Health experts caution against the consumption of raw milk due to the risk of bird flu. Researchers investigate the long-term efficacy of weight loss drugs like Ozempic, while Australian scientists make strides towards replacing insulin injections with a pill. 

Addiction treatment has evolved significantly over the last few decades. With the change in substance use patterns comes the change in how we help individuals recover from substances. From understanding how opioids impact brain function and the side effects of drug use to understanding the effectiveness of early prevention and equipping individuals with the right tools for long-term treatment, we can thank much of the advancements in addiction medicine to our special guest this week.  In this conversation, Dr. Powers and George Joseph are joined by a true pioneer in addiction medicine, Dr. Mark S. Gold. Revered as "The Godfather of addiction medicine," Dr. Gold is a renowned Addiction Medicine Expert, Speaker, Author, Professor, and Researcher with extensive accolades and credentials. Starting his career in translational neuroscience in 1972, Dr. Gold's theories have changed the [addiction] field, stimulated research, and led to new treatments.  With over 40 years in the addiction treatment space, Dr. Gold has developed models for understanding the effects of tobacco, cocaine, opiates, and other drugs, as well as food, on the brain and behavior. As an inventor, Dr. Gold's work has resulted in many patents, from his first, clonidine use in opioid withdrawal to his most recent on the use of anti-addiction medications in the treatment of hedonic overeating and the use of central site photoplethysmography, medication Administration and Safety Granted in 2018. To read more about Dr. Mark Gold and his contributions to the addiction treatment industry, you can learn more at his website: https://www.drmarkgold.com/about-dr-mark-gold-world-renowned-addiction-medicine-expert-doctor/   Topics Discussed: Understanding the waves of addiction to better support the addicted individual The relationship between overdose risks, early prevention and treatment Why language matters and how to de-stigmatize drug addiction The underlying issues behind self-prescribed Naloxone Why long-term treatment is the most effective and sustainable approach   Connect with us on Social:   IG: https://www.instagram.com/positiverecoverymd/  FB: https://www.facebook.com/groups/positiverecoverymd/ FB Group: https://www.facebook.com/groups/577870242872032  TT: https://www.tiktok.com/@positiverecoverycenter  YT: https://www.youtube.com/channel/UC4JcDF1gjlYch4V4iBbCgZg Additional Links: Want to receive the daily Positive Intervention from Dr. Powers' Positive Recovery Daily Guide? Subscribe here! https://lp.constantcontactpages.com/su/OtK48nO/dailypositiverecovery.   About Positive Recovery Centers: Positive Recovery Centers is a strengths-based addiction treatment program with locations across Texas. We offer a full continuum of care, from medical detox to sober living, all supported by an ever-growing alumni community network.  Our evidence-based curriculum blends the best of the old with the new, supporting our mission: Recovery is best pursued when meaningful, intentional, positive habits are formed through empowerment and resilience instead of negativity and shame. If you or someone you know needs addiction treatment, please visit the website, or call the number below to schedule an assessment. We are here to help! Call: 877-476-2743 Address: 902 West Alabama Street, Houston, Texas 77006 Website: https://positiverecovery.com  Services: https://positiverecovery.com/services/  FAQ: https://positiverecovery.com/faq/   

Lead Story: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration Drug and Alcohol Dependence The authors studied the effect of receiving MOUD during incarceration in New York City jails on non-fatal overdose events during the year after discharge. Data were analyzed for patients with OUD incarcerated between 2011-2017 who either received MOUD during the 3 days before release (n=8660) or did not receive MOUD just prior to release (n=10,163). After controlling for covariates, those receiving MOUD had a significant reduction in non-fatal overdoses during the 14 days after release (adjusted HR: 0.49; 95% CI = 0.33-0.74). However, there was no reduction in non-fatal overdoses during the remainder of the 1 year after release. The authors speculate that this lack of benefit beyond 14 days may be due to failure to transition to outpatient MOUD after release. They conclude that MOUD in jail could be lifesaving and that it is important to ensure MOUD continues after release. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

He's on the phone with Simon.

Some construction sites might falsely believe that since narcotics are forbidden at the work site, this just simply shouldn't be a problem, or they might even think that having Naloxone might make people feel more of a sense of license that they can misuse narcotics at or near the workplace.  In this episode of Construction Blueprints, Jonathan Oppenheim, North America Regional Construction Leader, is joined by Jeff Levin Schurz, a Physician, Managing Director at WTW, and our North American Population Health Leader.  In the podcast, we explore the use of Naloxone as a potential life saving practice in the construction industry. This is an incredibly important topic as fatal drug overdoses have doubled in the U.S. since 2015. For more information on the topic discussed in the podcast, please visit the following sources: Surgeon General Advisory on Naloxone and Opioid Overdose (2022)

In this week's special episode WSPHA Director, Megan Moore, and Admin Coordinator, Gloria Rogers, interview Representative Greg Nance (LD 23, Bainbridge Island) about HB 2112, which would offer opioid overdose solutions and education in institutions of higher education. We talk about what to do after a bill passes and how you can get involved if you are a student in college right now.

Alexey Navalny's mother says she's seen her son's body. AT&T is experiencing an outage that's making it hard for thousands of customers to call, text, or access the internet. President Joe Biden might take matters into his own hands when it comes to the southern border. Dozens of states are offering free opioid reversal treatments – we'll tell you how & where. A trial is underway that'll decide whether a Texas school district can have any say over the length of students' hair. And, why NASA is watching today's lunar landing very closely. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Over 100,000 people died in 2022 because of drug overdoses, with the majority of them using illegal opioids in ways other than injection, the latest CDC data shows. Substance use disorder expert Michael Fingerhood at Johns Hopkins says while interdiction … What might help combat opioid overdose deaths? Elizabeth Tracey reports Read More »

Today - we dive into a significant development in the fight against opioid overdose: the FDA's approval of Opvee.Support the show: https://www.myheraldreview.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

A new edition of NY&, our civics series, looks at how local policy impact what policing looks like across communities in New York state. As part of WMHT'S Opioids in New York series, Public health officials and patients share how medication assisted treatment can assist with addiction recovery at Greene County Family Planning. The Rensselaer County Heroin Coalition is committed to addressing the opioid overdose crisis by providing support and awareness to the issue. Explore more: nynow.org

In this episode of the Survival Medicine Podcast, Dr. Joe and Nurse Practitioner Amy Alton discuss a wide range of medical topics from tic disorders to acid relux to wound care. Amy gives a thorough overview of gastro-esophageal reflux disease (GERD) and the various treatments used, their advantages and disadvantages.  Dr. Joe Alton discusses wound care and how proper irrigation of an open wound helps healing and increases survival rates. Plus, a news story out of New York City that suggests the government there is asking everyone to carry anti-overdose drugs like Narcan(r) due to an alarming death rate from fentanyl. Dr. Alton also takes a question from an audience member about tic disorders, especially in kids. There's not much that the Altons won't cover in the Survival Medicine Podcast! Wishing you the best of health in good times or bad, Amy and Joe Alton Hey, don't forget to check out our entire line of quality medical kits (including suture kits) at store.doomandbloom.net. Also, our Book Excellence Award-winning 700-page SURVIVAL MEDICINE HANDBOOK: THE ESSENTIAL GUIDE FOR WHEN HELP IS NOT ON THE WAY is now available in black and white on Amazon and in color and color spiral-bound versions at store.doomandbloom.net.

In this episode Dr. Gillian Beauchamp sits down with Dr. Alex Manini to discuss single nucleotide polymorphisms (SNPs) of the Mu receptor and how they may relate to overdose severity of opioid overdose. 

Author Xinyan Wu discusses the article, "Parallel Development: Medicalization and Decriminalization in the Changing Media Framing of the Opioid Overdose Crisis" published in Socius: Sociological Research for a Dynamic World.

With deaths from opioid overdoses rocketing to more than 100,000 people each year, the US has moved to make the drug Naloxone available to buy in pharmacies for the first time there this week. The nasal spray treatment can revive people who have overdosed within minutes. Claudia Hammond is joined by Dr Ann Robinson to hear how the drug works, and what lessons the US can learn from how other countries around the world are using it. We also hear from the first polar research team to try to tackle taboos over menstruation by training the next generation of Arctic and Antarctic scientists how to deal with having your period during an expedition. Claudia and Ann look at new research suggesting the morning after pill becomes more effective when taken with anti-inflammatory drugs. And we find out whether opposites do truly attract, as a new study on romantic relationships uncovers what happy couples do and don't have in common. Image Credit: Brittany Murray/MediaNews Group/Long Beach Press-Telegram via Getty Images Presenter: Claudia Hammond Producer: Dan Welsh

The federal government has awarded a rural southeast Montana health care center almost $2 million to address regional opioid-related overdose risks.

Idalia made landfall in Florida as a Category 3 hurricane and is weakening as it moves toward other southeastern states. The lifesaving drug Narcan meant to reverse opioid overdoses will be available over-the-counter next week. We'll update you on two economic data points the Federal Reserve watches closely. The IRS is reminding employers it can help its employees pay off their student loans. Plus, CNN has a new CEO.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

August 30, 2023 - We sit down with the co-chairs of the state's interagency task force on opioid overdoses, Dr. Chinazo Cunningham, commissioner for the State Office of Addiction Services and Supports, and Dr. Jim McDonald, commissioner for the state Department of Health.

Drug agencies issue letter addressing the prescription stimulant shortage; electronic transfer of controlled substances given green light; oral contraceptives recalled; expanded indication for Ebola vaccine; and a new over-the-counter opioid overdose treatment.

This past year the festival community has faced several tragic events that has brought into question what safety measures (or lack thereof) event producers and local law enforcement have been taking to make sure that attendees are taken care of. In this episode, I'm sharing my thoughts on these incidents, what changes I'd like to see in event safety and how I think we can all contribute to making our community a safer space.

In this podcast we talk with Dr. Daniel Colby, an emergency physician, about the dangers of opioid misuse, how to recognize an overdose and how and when to administer Naloxone.

Host Mikaela Lefrak speaks with the health commissioner on plans to bolster the state's response to opioid overdoses, as well as the importance of harm reduction with health experts.

The nation's drug regulator approved the first over-the-counter opioid overdose reversal nasal spray on Wednesday. Katherine Ellen Foley talks with host Ruth Reader about the significance of Narcan being available without a prescription and the hopes for how it might positively impact the opioid overdose epidemic in the U.S.

Thank you to today's sponsor Purple Garden! Browse psychic, astrology & tarot readings & use code RCC to get $10 credit on your first reading - https://trypurplegarden.com/rcc

In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were almost twice as likely as men to experience an opioid overdose. A team of scientists from Oregon State University, Oregon Health & Science University and the Oregon Department of Corrections shared these findings which were published in the Journal of Substance Use and Addiction Treatment. The study looked at both fatal and non-fatal opioid overdoses using data collected from the Department of Corrections, state Medicaid insurance claims for emergency room and hospital admissions, as well as death certificates. Joining us are Dan Hartung, a professor in the College of Pharmacy at Oregon State University and Elizabeth Waddell, an associate professor at the OHSU-PSU School of Public Health, to talk about the research and new efforts in Oregon to expand access to substance use treatment both during and after incarceration.

2023 SCCM PharmD Star Researchers 03:10 – Restrictive Resuscitation in Patients with Sepsis: A Systematic Review with Trial Sequential analysis with Sylvia Stefanos, PharmD  10:50 – Incidence of Acute Kidney Injury in Traumatic Brain Injury Patients Treated with Hypertonic Saline with Jesse Briscoe, PharmD 19:42 – Comparison of Factor Products for Uncontrolled Bleeding Related to Cardiac Surgery with Lauren Caldwell, PharmD, BCCCP 28:00 – Validation of Heparin-Induced Thrombocytopenia Risk Stratification Tools in Post-Surgical Cardiovascular Patients with Shahristan Kokoy, PharmD, BCPS 39:16 – Naloxone Co-prescribing for Emergency Medicine and Trauma Patients at High-risk for Opioid Overdose with William Peppard, PharmD, BCPS, FCCM 52:20 – Incidence of Detectable Drug Levels with Inhaled Aminoglycoside Therapy in Critically Ill Adults with Jenny Schultheis, PharmD, BCPS, BCCCP 63:28 – Evaluation of Achieving Targeted Vancomycin Levels in Augmented Renal Clearance with Sydney Wilson, PharmD 73:30 – Vancomycin and Piperacillin/tazobactam or Cefepime and Sepsis-Associated AKI Trajectory with Michael Behal, PharmD, BCCCP PharmacyToDose.Com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices